Mutational profiling of resected intrahepatic cholangiocarcinoma.

被引：1
|
作者：
Pak, Linda Ma
Goldman, Debra
Gonen, Mithat
Allen, Peter J.
Balachandran, Vinod P.
D'Angelica, Michael Ian
DeMatteo, Ronald P.
Kingham, T. Peter
Simpson, Amber
Hechtman, Jaclyn Frances
Vakiani, Efsevia
Sigel, Carlie S.
Lowery, Maeve Aine
Jarnagin, William R.
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15675
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15675
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Resectability and survival outcome in real world practice of 720 cholangiocarcinoma patients: intrahepatic, perihilar and distal cholangiocarcinoma.
    Sarkhampee, Poowanai
    Ouransatien, Weeris
    Lertsawatvicha, Nithi
    Chansitthichock, Satsawat
    Wattanarath, Paiwan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [32] Phase II study of lenvatinib in combination with GEMOX chemotherapy for advanced intrahepatic cholangiocarcinoma.
    Shi, Guo-Ming
    Jian, Zhou
    Fan, Jia
    Huang, Xiao-Yong
    Wu, Dong
    Liang, Fei
    Lu, Jia-Cheng
    Yang, Guo-Huan
    Chen, Yi
    Ge, Ning-Ling
    Ji, Yuan
    Hou, Y. Y.
    Sun, Hui-Chuan
    Qiu, Shuang-Jian
    Ye, Qing-Hai
    Huang, Xiao-Wu
    Shi, Ying-Hong
    Gao, Qiang
    Yang, Xin-Rong
    Wang, Zheng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Immunohistochemical and genetic profiles do not predict behavior of mixed hepatocellular intrahepatic cholangiocarcinoma.
    Sucre, Santiago
    Paredes, Rodrigo
    Peters, Mary Linton Bounetheau
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 516 - 516
  • [34] The impact of tumor genomic profile on the effectiveness of adjuvant chemotherapy in resectable intrahepatic cholangiocarcinoma.
    Marcus, Rebecca
    Lillemoe, Heather A.
    Abdel-Wahab, Reham
    Shroff, Rachna T.
    Javle, Milind M.
    Aloia, Thomas A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [35] THERAPEUTIC UTILIZATION OF MOLECULAR PROFILING FOR INTRAHEPATIC CHOLANGIOCARCINOMA
    Besharati, Sepideh
    Shaikh, Sofia
    Mansukhani, Mahesh
    Remotti, Helen
    HEPATOLOGY, 2022, 76 : S1353 - S1353
  • [36] Comprehensive genomic profiling of intrahepatic and extrahepatic cholangiocarcinoma
    Vignali, P.
    Bruno, R.
    Poma, A. M.
    Signorini, F.
    Vivaldi, C.
    Genovesi, V.
    Salani, F.
    Lorenzo, F.
    Cremolini, C.
    Ugolini, C.
    VIRCHOWS ARCHIV, 2024, 485 : S12 - S12
  • [37] Transplantation for intrahepatic cholangiocarcinoma and the role of genetic profiling
    Kodali, S.
    Javle, M.
    De Armas, A. Danner
    McMillan, R.
    Victor, D.
    Shetty, A.
    McFadden, R.
    Galati, J.
    Egwim, C.
    Ankoma-Sey, V.
    Duchini, A.
    Abdelrahim, M.
    Heyne, K.
    Brombosz, E.
    Moore, L.
    Hobeika, M.
    Mobley, C.
    Saharia, A.
    Ghobrial, R. M.
    TRANSPLANTATION, 2022, 106 (8S) : 11 - 12
  • [38] Genomic Profiling of Intrahepatic Metastases Versus Localized Satellites in Intrahepatic Cholangiocarcinoma
    Chun, Y.
    Karpinets, T.
    Zhan, J.
    Song, X.
    Javle, M.
    Shroff, R.
    Futreal, A.
    Vauthey, J.
    Estrella, J.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S24 - S24
  • [39] Combined hepatocellular and cholangiocarcinoma.
    Dondero, F
    Regimbeau, JM
    Cazals-Hatem, D
    Terris, B
    Flejou, JF
    Degott, C
    Belghiti, J
    HEPATOLOGY, 2001, 34 (04) : 669A - 669A
  • [40] Association of liver-directed local therapy with overall survival in metastatic intrahepatic cholangiocarcinoma.
    Sebastian, Nikhil
    Miller, Eric David
    Williams, Terence M.
    Noonan, Anne M.
    Hays, John L.
    Pardo, Dayssy Alexandra Diaz
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345